Prolia and Osteoporosis
Links shared publicly online about this topic
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:36 pm By:
Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for the treat... http://bit.ly/cUXDUl
Prolia approved for postmenopausal osteoporosis - ONA
oncologynurseadvisor.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 2, 2010 at 3:00 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Prolia approved for postmenopausal osteoporosis http://goo.gl/fb/bGLvd
Prolia approved for postmenopausal osteoporosis - MPR
empr.com — “The FDA has approved Prolia (denosumab, from Amgen) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.” View full resource at empr.com
Most Recently Shared on June 2, 2010 at 3:17 pm By:
MPR News: Prolia approved for postmenopausal osteoporosis: The FDA has approved Prolia (denosumab, from Amgen) for... http://bit.ly/a0ZOXp
Prolia Approved for Post-Menopausal Women With Osteoporosis Information on Healthline
healthline.com — “Read about Postmenopausal Osteoporosis, and other breaking health care stories in the Health Day News section of Healthline.” View full resource at healthline.com
Most Recently Shared on June 2, 2010 at 9:27 pm By:
Women's Health Line Health Site
Prolia Approved for Post-Menopausal Women With Osteoporosis http://w.sns.ly/Dzz42 #women #womenshealth
New Injectable Osteoporosis Drug Prolia Gains FDA Approval
medicalnewstoday.com — “Prolia, a new injectable drug to treat osteoporosis in postmenopausal women at high risk of fractures has been approved by the US Food and Drug Administration (FDA).In a statement on it” View full resource at medicalnewstoday.com
Most Recently Shared on June 3, 2010 at 6:14 pm By:
New Injectable Osteoporosis Drug Prolia Gains FDA Approval http://mnt.to/3Dvf #healthnews
Medicine and Technology [part of HCPLive]: Prolia (denosumab) approved by the FDA for the treatment of osteoporosis
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: Prolia (denosumab) approved by the FDA for the treatment of osteoporosis” View full resource at medicineandtechnology.com
Most Recently Shared on June 2, 2010 at 7:14 pm By:
Joseph Kim, MD, MPH Doctor and Physician
Prolia (denosumab) approved by the FDA for the treatment of osteoporosis http://bit.ly/ctuyuG
Prolia (denosumab), Amgen Osteoporosis Drug, Advances in Europe - Health Blog - WSJ
blogs.wsj.com — “Amgen is betting its future on a single bone drug.” View full resource at blogs.wsj.com
Most Recently Shared on December 18, 2009 at 11:39 pm By:
Prolia (denosumab), Amgen Osteoporosis Drug, Advances in Europe - Health Blog - WSJ - http://shar.es/aDkeD
Amgen's Osteoporosis Drug Denosumab (Prolia) at FDA Panel - Health Blog - WSJ
blogs.wsj.com — “But several analysts said Amgen's experimental bone drug denosumab fared well enough to stay on track.” View full resource at blogs.wsj.com
Most Recently Shared on August 14, 2009 at 1:42 pm By:
Physician Assistants Health News Feed
Analysts react to FDA panel: http://tinyurl.com/p8dmla Amgen's future in Denosumab
Amgen's Osteoporosis Drug Denosumab (Prolia) at FDA Panel - Health Blog - WSJ
blogs.wsj.com — “But several analysts said Amgen's experimental bone drug denosumab fared well enough to stay on track.” View full resource at blogs.wsj.com
Most Recently Shared on August 14, 2009 at 1:18 pm By:
Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’ http://bit.ly/MQFNp
Prolia (denosumab), Amgen Osteoporosis Drug, Advances in Europe - Health Blog - WSJ
blogs.wsj.com — “Amgen is betting its future on a single bone drug.” View full resource at blogs.wsj.com
Most Recently Shared on December 18, 2009 at 4:18 pm By:
Amgen’s Next Big Thing Gets a Thumbs Up in Europe http://bit.ly/5549s0
FDA Approves Prolia, New Treatment for Osteopososis
webmd.com — “The FDA has approved twice-a-year Prolia injections to treat osteoporosis in patients at high risk of fracture. The biologic therapy shuts down the body's bone-breakdown mechanism.” View full resource at webmd.com
Most Recently Shared on June 2, 2010 at 9:06 pm By:
webMD: FDA Approves Prolia, New Treatment for Osteopososis http://bit.ly/biy5gQ Full http://bit.ly/aa5NPJ
PROLIA - New Product Releases - MPR
empr.com — “In postmenopausal women with osteoporosis: at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other therapy; to reduce incidence of vertebral, nonvertebral, and hip fractures.” View full resource at empr.com
Most Recently Shared on June 18, 2010 at 3:25 pm By:
MPR News: PROLIA: Denosumab 60mg/mL; soln for SC inj; preservative-free. http://bit.ly/bTrSX6
FDA Approves Amgen's Prolia (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
drugs.com — “Prolia (denosumab) is used to treat postmenopausal women with osteoporosis. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 2, 2010 at 11:55 pm By:
FDA Approves Prolia (denosumab) for Treatment of Postmenopausal Women With Osteoporosis - http://bit.ly/aF8OQu
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture
medicalnewstoday.com — “Amgen Inc. (Nasdaq: AMGN) announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high ris” View full resource at medicalnewstoday.com
Most Recently Shared on August 8, 2010 at 11:36 am By:
Women's Health Line Health Site
FDA Approves Amgen's Prolia(TM) (Denosumab) For Treatment Of Postmenopausal Women With Osteoporosis At... http://sns.ly/zJe48 #womenshealth
Clinical Cases and Images: CasesBlog: Denosumab (Prolia) is a monoclonal antibody that reduces fractures in osteoporosis
casesblog.blogspot.com — “Health News Updated Daily by an Assistant Professor at University of Chicago, Internist and Allergist” View full resource at casesblog.blogspot.com
Most Recently Shared on August 12, 2009 at 11:08 am By:
Richard L.Trader,Sr Physician Assistant, Therapist, and Health Executive
Denosumab is a monoclonal antibody that reduces fractures in osteoporosis: New osteoporosis medication denosumab.. http://bit.ly/4cg1iG
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
